Current pharmacotherapy of central precocious puberty by GnRH analogs: certainties and uncertainties

Author： Bertelloni Silvano   Baroncelli Giampiero I  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.12, 2013-08, pp. : 1627-1639

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of GnRH antagonists in the treatment of precocious puberty

By Roth Christian  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1253-1259

Informa Healthcare

Access to resources Recommend Favorite

Clinical suppression of precocious puberty with cetrorelix after failed treatment with GnRH agonist in a girl with gonadotrophin-independent precocious puberty

By Wu Meng-Hsing   Lin Shio-Jean   Wu Li-Hsiang   Cheng Yueh-Chin   Chou Yen-Yin   Pan Hsien-An  

Reproductive BioMedicine Online, Vol. 11, Iss. 1, 2005-07 ,pp. : 18-21

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Central Precocious Puberty: Current Treatment Options

By Franco Antoniazzi   Giorgio Zamboni  

Pediatric Drugs, Vol. 6, Iss. 4, 2004-01 ,pp. : 211-231

Adis International

Access to resources Recommend Favorite

Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?

By  

Current Cancer Drug Targets, Vol. 6, Iss. 3, 2006-05 ,pp. : 257-269

Bentham Science Publishers

Access to resources Recommend Favorite

GnRH antagonists in IVF

By Kolibianakis Efstratios M   Tarlatzis Basil   Devroey Paul  

Reproductive BioMedicine Online, Vol. 10, Iss. 6, 2005-06 ,pp. : 705-712

Reproductive Healthcare Ltd

Access to resources Recommend Favorite